Toxoplasma gondii in Cats: Feline Toxoplasmosis in Brazil

Etiology and Life Cycle

Toxoplasma gondii is an obligate intracellular apicomplexan parasite with a heteroxenous life cycle. Felids, including domestic cats (Felis catus), serve as the definitive host in which sexual reproduction occurs exclusively within the intestinal epithelium [1, 2]. The parasite undergoes a complex developmental program: ingestion of tissue cysts (bradyzoites) or oocysts (sporozoites) by a naive cat leads to excystation in the small intestine, followed by multiple rounds of asexual multiplication (merogony) and subsequent gametogony that culminates in the formation of unsporulated oocysts [1, 3]. These oocysts are shed in feces and sporulate in the environment to become infectious [4]. Sporulation requires oxygen and moderate temperatures; the process is disrupted when the glutaredoxin 5 gene (TGME49_227100) is lost, preventing oocyst wall formation and sporulation [4]. The entero-epithelial cycle is tightly regulated by host microRNAs, with dynamic changes in miRNA expression observed in the feline small intestine during infection [2]. Recent advances using single-cell transcriptomics have provided a detailed atlas of sexual development, identifying distinct transcriptional programs for merozoites, gametocytes, and oocyst formation [1]. Long-term feeder cell-free cat intestinal organoid cultures now enable in vitro study of the sexual cycle, bypassing the need for live animal experimentation [3]. Retinal cells and intestinal organoid-derived monolayers can also be used to enhance pre-sexual and sexual differentiation [5].

Epidemiology of Toxoplasmosis in Cats in Brazil

Brazil presents a unique epidemiological landscape for feline toxoplasmosis due to its large feral cat populations, high environmental oocyst contamination, and socioeconomic disparities. Seroprevalence studies have demonstrated widespread exposure. In the Pantanal region of Mato Grosso, high seroprevalence rates of T. gondii were documented in dogs, with parallel exposure expected in sympatric cats [6]. In urban informal settlements in Salvador, Brazil, seroprevalence in companion animals (including cats) was associated with environmental degradation and social marginalization [7, 8]. A spatial epidemiological study in Northwestern São Paulo reported prevalence and spatial clustering of T. gondii infection in both domestic and stray cats, with stray cats showing higher seropositivity [9]. Risk factors include free-roaming behavior, hunting of intermediate hosts (rodents, birds), and access to raw or undercooked meat [8, 9]. In a municipal neutering program in Brazil, T. gondii DNA was detected in reproductive tissues of cats, indicating potential vertical transmission [10]. Coinfections with hemotropic agents (e.g., Mycoplasma spp., Bartonella spp.) are common in Brazilian cats and may modulate disease severity [11]. A mouse-virulent recombinant type I/III T. gondii strain was isolated from an immunosuppressed cat co-infected with FeLV-C in Brazil, highlighting the emergence of atypical genotypes [12].

Clinical Signs and Pathology

Most immunocompetent cats infected with T. gondii remain subclinical. Clinical disease occurs primarily in kittens, immunosuppressed adults, or cats with concurrent retroviral infections (FeLV, FIV) [12]. The most common clinical manifestations include fever, lethargy, anorexia, and lymphadenopathy. Ocular toxoplasmosis presents as uveitis, chorioretinitis, and anterior chamber inflammation. Neurological signs (seizures, ataxia, circling, behavioral changes) result from meningoencephalitis or focal granulomas [13]. Respiratory signs (dyspnea, tachypnea) are associated with interstitial pneumonia or nodular pyogranulomatous pneumonia, which has also been described in a cat infected with Besnoitia darlingi but can be mimicked by T. gondii [14]. Hepatic involvement leads to icterus and elevated liver enzymes. Myocarditis and pancreatitis are less common but documented [13]. Pathologically, the hallmark lesion is multifocal necrosis with mixed inflammatory infiltrates (neutrophils, macrophages, lymphocytes) in affected organs. Tissue cysts (bradyzoites) are found in skeletal muscle, myocardium, and brain, often without surrounding inflammation. In the intestine, sexual stages (meronts, gamonts, oocysts) are present in enterocytes during the acute shedding phase [1, 2]. Multi-omics analyses have shown that T. gondii alters the gut microbiota and systemic metabolism in cats, with shifts in bacterial phyla and serum metabolite profiles [15].

Diagnostic Approaches

Diagnosis of feline toxoplasmosis requires a combination of serological, molecular, and parasitological methods. A comprehensive diagnostic algorithm is presented below.

graph TD
    A[Clinical suspicion: fever, uveitis, neurological signs], > B{Serology: IgG/IgM ELISA or IFAT}
    B, >|IgG positive, IgM negative| C[Chronic/latent infection; clinical signs likely due to other causes]
    B, >|IgG and IgM positive| D[Acute or reactivated infection]
    B, >|IgG negative, IgM positive| E[Recent infection; repeat serology in 2-4 weeks]
    D, > F{Confirm with molecular or parasitological methods}
    E, > F
    F, > G[PCR on blood, CSF, aqueous humor, or tissue]
    F, > H[Fecal flotation / PCR for oocysts]
    F, > I[Histopathology / immunohistochemistry]
    G, > J[Positive: active infection]
    H, > J
    I, > J
    J, > K[Initiate antiprotozoal therapy if clinical signs present]

Serology

Serological detection of anti-T. gondii IgG and IgM antibodies is the most common screening tool. Commercial ELISA kits and indirect fluorescent antibody tests (IFAT) are widely used [16]. Recombinant antigens, such as dense granule 14 (GRA14), have been developed for improved sensitivity and specificity in cats [16]. Another promising marker is MIC17A, which can detect both entero-epithelial and chronic stage infections [17]. Seroprevalence data from Brazil indicate that IgG seropositivity ranges from 30% to 70% depending on region and cat population [8, 9]. In a study from Hong Kong, demographic factors such as age, outdoor access, and diet were associated with seropositivity [18]. Similar risk factors apply in Brazil [8, 9].

Molecular Detection

PCR-based methods offer high sensitivity and specificity for detecting T. gondii DNA. Conventional PCR targeting the B1 gene or 529 bp repeat element is standard [19, 20, 21]. An antisense PCR assay has been developed to improve detection in domestic cats [22]. Real-time quantitative PCR (qPCR) allows quantification of parasite burden. Molecular detection in fecal samples is challenging due to low oocyst shedding and PCR inhibitors; however, PCR from fecal samples has been successfully applied in stray cats in Bangkok [19] and in Dhaka City [20]. In Brazil, PCR on reproductive tissues from neutering programs revealed T. gondii DNA in ovaries and testes, suggesting potential venereal or vertical transmission [10]. Molecular epidemiology using PCR-RFLP or microsatellite typing has identified clonal types I, II, III, and atypical recombinant strains in Brazilian cats [12, 11]. Metabarcoding of 18S rRNA can also detect T. gondii in fecal samples from free-roaming cats, though sensitivity may be lower than targeted PCR [23].

Parasitological and Histopathological Methods

Fecal flotation (e.g., Sheather's sugar solution) can detect oocysts, but oocyst shedding is intermittent and of short duration (1-3 weeks post-primary infection) [13]. Oocysts are morphologically indistinguishable from those of Hammondia hammondi and Besnoitia spp., necessitating molecular confirmation [14]. Histopathology of biopsied or necropsied tissues (brain, lung, liver, eye) reveals tachyzoites, tissue cysts, and associated inflammation. Immunohistochemistry using anti-T. gondii antibodies enhances detection [13]. Cytology of aqueous humor or CSF may show tachyzoites in acute cases.

Treatment

Treatment is indicated for cats with clinical toxoplasmosis. The standard protocol involves clindamycin (10-12 mg/kg orally or intramuscularly every 12 hours for 2-4 weeks) [13]. Alternative drugs include trimethoprim-sulfonamide combinations, azithromycin, or pyrimethamine combined with sulfadiazine. Supportive care (fluid therapy, nutritional support, anti-inflammatory doses of corticosteroids for ocular or neurological inflammation) is often necessary. In Brazil, access to veterinary care may be limited in informal settlements, leading to underdiagnosis and undertreatment [7, 8]. A live-attenuated T. gondii PruΔpp2a-c mutant has shown protective immunity in mice and cats, representing a potential vaccine candidate [24]. A recombinant GRA12 vaccine also demonstrated immunogenicity and protective efficacy in domestic cats [25]. These vaccines are not yet commercially available but hold promise for reducing oocyst shedding and clinical disease.

Control and Prevention

Control of toxoplasmosis in cats in Brazil requires a multi-pronged approach. Preventing environmental contamination with oocysts is paramount. Cats should be kept indoors to reduce hunting of intermediate hosts and ingestion of tissue cysts [9]. Feeding only commercial cooked or canned food eliminates the risk of meat-borne infection. Litter boxes should be cleaned daily (oocysts require 1-5 days to sporulate) and disposed of in sealed bags. Stray cat population management through trap-neuter-return (TNR) programs can reduce oocyst shedding in the environment [10, 9]. Public education on the zoonotic risks of oocyst exposure is critical, particularly in informal settlements where cats roam freely and soil contamination is high [7, 8]. Serological screening of cats in breeding catteries can identify chronic shedders, though most cats do not re-shed oocysts after primary infection unless immunosuppressed [13]. In Brazil, the high seroprevalence in dogs in the Pantanal [6] and in cats in São Paulo [9] underscores the need for region-specific control strategies. The AB blood group system phenotype does not influence susceptibility to T. gondii infection in cats [26]. Coinfections with hemotropic agents should be managed concurrently [11].

Conclusion

Toxoplasmosis in cats in Brazil is a significant veterinary and public health concern due to high seroprevalence, environmental contamination, and the presence of atypical parasite genotypes. Advances in molecular diagnostics, including antisense PCR [22] and recombinant antigen serology [17, 16], have improved detection. The development of intestinal organoid models [3, 5] and single-cell transcriptomics [1] has deepened understanding of sexual development. Vaccines [25, 24] and improved treatment protocols offer hope for better management. Continued surveillance using spatial epidemiology [9] and multi-omics approaches [15] will inform targeted control measures in both urban and rural settings.

References

[1] Alrubaye HS, Reilly SM, da Silva R, et al. A single-cell atlas of Toxoplasma sexual development in the feline intestinal tract. Nat Microbiol. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/42020723/

[2] Zhai B, Bao B, Xie SC, et al. Dynamic landscape of microRNA expression in the feline small intestine during Toxoplasma gondii infection. Parasit Vectors. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/41965856/

[3] Warschkau D, Hoffmann T, Laue M, et al. Long-term feeder cell-free cat intestinal organoid cultures to study Toxoplasma gondii's sexual development. Commun Biol. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/41691108/

[4] Xie F, Xie Y, Yang Y, et al. Loss of TGME49_227100 (Glutaredoxin 5) Disrupts Oocyst Formation and Sporulation in Toxoplasma gondii. Pathogens. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/41754403/

[5] Cancela S, Sena F, Pagotto R, et al. Protocol to enhance pre-sexual and sexual differentiation of Toxoplasma gondii using retinal cells and intestinal organoid-derived monolayers. STAR Protoc. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/41686642/

[6] Artiaga-Silva GL, de Lima Ruy Dias ÁF, Carvalho MR, et al. High Seroprevalence Rates of Toxoplasma gondii and Neospora caninum in Dogs in the Pantanal Region of Mato Grosso, Brazil. Acta Parasitol. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/41843222/

[7] Eyre MT, Wang JY, Carneiro IO, et al. Social marginalisation, environmental degradation and Toxoplasma gondii exposure in urban informal settlements in Brazil. PLoS Negl Trop Dis. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/42330015/

[8] Bazan L, Argibay HD, Borges-Silva W, et al. Seroprevalence and risk factors for Toxoplasma gondii infection in wild, domestic and companion animals in urban informal settlements from Salvador, Brazil. PLoS Negl Trop Dis. 2025. URL: https://pubmed.ncbi.nlm.nih.gov/41401226/

[9] Murata FHA, Barboza JP, Tasso FF, et al. Prevalence and spatial distribution of Toxoplasma gondii infection in domestic and stray cats (Felis catus) in Northwestern São Paulo, Brazil. Spat Spatiotemporal Epidemiol. 2025. URL: https://pubmed.ncbi.nlm.nih.gov/40935507/

[10] Murata FHA, Barboza JP, de Souza CAG, et al. Investigation of Toxoplasma gondii in reproductive tissues of companion animals from a municipal neutering program. Vet Parasitol Reg Stud Reports. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/41651631/

[11] Ríos-Úsuga C, Rendón-Ramos LM, Jaramillo-Delgado IL, et al. Disclosing coinfections: The interaction between Toxoplasma gondii and hemotropic agents in Colombian dogs and cats. Comp Immunol Microbiol Infect Dis. 2025. URL: https://pubmed.ncbi.nlm.nih.gov/40712328/ *** Disclaimer: This article is for educational and informational purposes only. It is not intended to substitute for professional veterinary advice, diagnosis, treatment, or regulatory guidance. Always consult a licensed veterinarian or qualified specialist regarding animal health, disease diagnosis, and therapeutic decisions.

[12] Fonseca J, Almeida P, Campos S, et al. Identification of a mouse-virulent recombinant type I/III Toxoplasma gondii strain in liver cytology of an immunosuppressed cat infected with FeLV-C subgroup. Vet Res Commun. 2025. URL: https://pubmed.ncbi.nlm.nih.gov/41108469/

[13] Zhao D, Liao Y, Liu H, et al. Comprehensive diagnostic approaches to feline toxoplasmosis: Bridging traditional methods and emerging technologies. Virulence. 2025. URL: https://pubmed.ncbi.nlm.nih.gov/40974007/

[14] Kaur J, Giannino D, Taylor R, et al. Nodular pyogranulomatous pneumonia associated with Besnoitia darlingi infection in a cat. J Vet Diagn Invest. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/41782300/

[15] Zhao JX, Wang XY, Zhang X, et al. Toxoplasma gondii alters gut microbiota and systemic metabolism in cats: A multi-omics approach. Vet J. 2025. URL: https://pubmed.ncbi.nlm.nih.gov/41015376/

[16] Ha HT, Suwan E, Kengradomkij C, et al. Development and evaluation of recombinant dense granule 14 for serological diagnosis of Toxoplasma gondii infection in domestic cats. Sci Rep. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/41708729/

[17] Günay-Esiyok Ö, Koçkaya ES, Yılmaz R, et al. The Potential of MIC17A both as an Entero-epithelial and Chronic Stage Marker for Detection of Feline Toxoplasmosis. Curr Microbiol. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/41874672/

[18] Elsohaby I, Zubair M, Baqar Z, et al. Seroprevalence of Toxoplasma gondii and associated demographic factors in privately-owned dogs, cats, and community cats in Hong Kong. BMC Vet Res. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/42135800/

[19] Kengradomkij C, Chimnoi W, Kamyingkird K, et al. PCR detection of Toxoplasma gondii DNA in fecal samples from stray cats in Bangkok Metropolitan, Thailand. Food Waterborne Parasitol. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/42094705/

[20] Hasan MF, Nahar A, Harun AB, et al. Serological and molecular investigation of Toxoplasma gondii in domestic cats in Dhaka City, Bangladesh. Food Waterborne Parasitol. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/41778096/

[21] Alkhatatbeh SK, Lafi SQ, Hammad HB, et al. The first seroprevalence and molecular detection of toxoplasmosis infecting cats in Jordan with associated risk factors. Vet Parasitol Reg Stud Reports. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/41741047/

[22] Li YY, Bai SY, Yu HQ, et al. Development and evaluation of an antisense PCR assay for Toxoplasma gondii detection in domestic cats. Vet Parasitol. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/41724116/

[23] Travieso-Aja MDM, Henríquez-Hernández LA, Hernández-Álvarez E, et al. Low Zoonotic Pathogen Burden in Free-Roaming Cats Revealed by 18S rRNA Metabarcoding: A Baseline Study from an Insular Natura 2000 Site in Spain. Animals (Basel). 2026. URL: https://pubmed.ncbi.nlm.nih.gov/41681411/

[24] Xie SC, Lv YH, Wang M, et al. Live-attenuated Toxoplasma gondii PruΔpp2a-c mutant elicits protective immunity against toxoplasmosis in mice and cats. Int J Parasitol. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/40783178/

[25] Yang J, Nie L, Song Y, et al. Immunogenicity and Protective Efficacy of a Recombinant Toxoplasma gondii GRA12 Vaccine in Domestic Cats. Vaccines (Basel). 2025. URL: https://pubmed.ncbi.nlm.nih.gov/40872935/

[26] Spada E, Tattarletti G, Proverbio D, et al. The AB Blood Group System Phenotype Does Not Play a Role in Toxoplasma gondii Infection in Cats. Pathogens. 2025. URL: https://pubmed.ncbi.nlm.nih.gov/41471183/

[27] Pinto GOA, Silva RAD, Oliveira PRF, et al. Molecular detection of Toxoplasma gondii in an aborted equine fetus and serological evidence of infection in mares enrolled in embryo transfer programs in Brazil. J Equine Vet Sci. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/42252005/

[28] Rehman FT, Ahmad U, Sardar R, et al. Molecular epidemiology and genetic profiling of Anaplasma ovis, Bartonella sp., and Toxoplasma gondii in domestic cats. Comp Immunol Microbiol Infect Dis. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/42217308/

[29] Nguyen NPN, Nguyen TT, Phanpha C, et al. Occurrence of Toxoplasma gondii and Neospora caninum Antibodies in Pet Cats and Dogs in Pathum Thani, Thailand. Trop Med Infect Dis. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/42042950/

[30] Biswas PK, Aryal D, Tarak AN, et al. Genotype distribution and risk factors of Toxoplasma gondii infection in animals of Trishal, Bangladesh. PLoS One. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/41528989/

[31] Didkowska A, Kołodziej-Sobocińska M, Matusik K, et al. Toxoplasma gondii in wild felides in Poland. BMC Vet Res. 2025. URL: https://pubmed.ncbi.nlm.nih.gov/41387866/

[32] Lider LA, Kiyan V, Mannapova NE, et al. Seroprevalence of Toxoplasma gondii infection in urban client-owned cats in Kazakhstan. Vet Res Commun. 2025. URL: https://pubmed.ncbi.nlm.nih.gov/40875169/

[33] Schanz ML, Zhao F, Zadeii KE, et al. The cat's out of the bag: Toxoplasma gondii provides further insight into myeloid-mediated host defense. Immunohorizons. 2025. URL: https://pubmed.ncbi.nlm.nih.gov/40854593/

[34] Yazicioglu T, Cetinkaya H. Prevalence and Sequence Analysis of Vector-Borne Zoonotic Diseases in Stray Cats in Istanbul. Vet Med Sci. 2025. URL: https://pubmed.ncbi.nlm.nih.gov/40788191/

[35] Antolová D, Valentová D, Strišková K, et al. Prevalence of intestinal parasites in owned and shelter cats in Slovakia and felines from Slovak Zoos: A three-year survey with special focus on Toxoplasma gondii. Curr Res Parasitol Vector Borne Dis. 2025. URL: https://pubmed.ncbi.nlm.nih.gov/40734659/